Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-13003162Phase 4Completed
Phase 4, open-label trial of etomidate and propofol in No canonical single disease; term refers to multiple upper gastrointestinal tract diseases (2 arms), sponsored by Army Specialized Medical Center. Primary endpoints: Hemodynamic changes and Adverse reactions. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-13003162.